1. Home
  2. Analysis
  3. Gastrografin
  4. Urticaria

Gastrografin and Urticaria - a phase IV clinical study of FDA data

Summary:

Urticaria is reported as a side effect among people who take Gastrografin (diatrizoate meglumine; diatrizoate sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ultravist 300, and have Computerised tomogram abdomen.

The phase IV clinical study analyzes which people have Urticaria when taking Gastrografin. It is created by eHealthMe based on reports of 519 people who have side effects when taking Gastrografin from the FDA, and is updated regularly.

What is Gastrografin?

Gastrografin has active ingredients of diatrizoate meglumine; diatrizoate sodium. eHealthMe is studying from 523 Gastrografin users. Check the latest studies of Gastrografin.

What is Urticaria?

Urticaria (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,613 drugs and 2,954 conditions by eHealthMe. Check the latest studies of Urticaria.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

519 people reported to have side effects when taking Gastrografin.
Among them, 36 people (6.94%) have Urticaria.

Could Gastrografin cause Urticaria?

Among these 36 people:

How long have people been on Gastrografin when they have Urticaria? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Urticaria when taking Gastrografin? *

  • female: 60 %
  • male: 40 %

What is the age of people who have Urticaria when taking Gastrografin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 6.45 %
  • 30-39: 12.9 %
  • 40-49: 19.35 %
  • 50-59: 25.81 %
  • 60+: 35.48 %

What are other drugs people take besides Gastrografin? *

  1. Ultravist 300: 19 people, 52.78%
  2. Ultravist 370: 5 people, 13.89%
  3. Ultravist: 4 people, 11.11%
  4. Insulin: 1 person, 2.78%
  5. Benadryl: 1 person, 2.78%
  6. Celexa: 1 person, 2.78%
  7. Coumadin: 1 person, 2.78%
  8. Fluoxetine: 1 person, 2.78%
  9. Glyburide: 1 person, 2.78%
  10. Imipenem And Cilastatin: 1 person, 2.78%

What are other side effects people have besides Urticaria? *

  1. Itching: 11 people, 30.56%
  2. Rashes (redness): 5 people, 13.89%
  3. Eye Pruritus (eye itching): 3 people, 8.33%
  4. Dyspnea (difficult or laboured breathing): 3 people, 8.33%
  5. Throat Irritation: 2 people, 5.56%
  6. Pruritus Generalised (generalized itching): 2 people, 5.56%
  7. Infusion Related Reaction: 2 people, 5.56%
  8. Eye Swelling: 2 people, 5.56%
  9. Laryngeal Oedema (swelling of larynx): 2 people, 5.56%
  10. Lip Swelling: 2 people, 5.56%

What are the existing conditions these people have? *

  1. Computerised Tomogram Abdomen: 22 people, 61.11%
  2. Abdominal Pain: 5 people, 13.89%
  3. Appendicitis (inflammation of the appendix): 2 people, 5.56%
  4. Renal Neoplasm (kidney tumour): 1 person, 2.78%
  5. Pancreatitis Acute (sudden inflammation of pancreas): 1 person, 2.78%
  6. High Blood Pressure: 1 person, 2.78%
  7. Gallbladder Disorder: 1 person, 2.78%
  8. Fever: 1 person, 2.78%
  9. Diabetes: 1 person, 2.78%
  10. Chest Pain: 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Gastrografin and have Urticaria?

- Check whether Urticaria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gastrografin:

Urticaria treatments and more:

How severe was Urticaria and when was it recovered:

Expand to all the drugs that have ingredients of diatrizoate meglumine; diatrizoate sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gastrografin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urticaria:

Browse all the conditions that are associated with Urticaria:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on diatrizoate meglumine; diatrizoate sodium (the active ingredients of Gastrografin) and Gastrografin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.